Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer.

@article{Sakuma2011PathologicalTR,
  title={Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer.},
  author={Kaori Sakuma and Masafumi Kurosumi and Hanako Oba and Yasuhito Kobayashi and Hiroyuki Takei and Kenichi Inoue and Toshio Tabei and Tetsunari Oyama},
  journal={Experimental and therapeutic medicine},
  year={2011},
  volume={2 2},
  pages={257-264}
}
Although triple-negative breast cancer (TNBC) is associated with a poor prognosis, recent reports have indicated that a higher proportion of TNBC patients shows a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) than is the case for non-TNBC patients. The aim of this study was to identify markers that predict pCR to NAC in TNBC patients, and to clarify prognostic factors that affect the outcome of TNBC patients with residual disease (RD) after NAC. Among 44 TNBC patients… CONTINUE READING
6 Citations
33 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 33 references

, the so - called triple - negative phenotype : a population - based study from the california cancer registry

  • BG haffty, Q Yang, +5 authors W hait
  • 2007

Similar Papers

Loading similar papers…